Robenacoxib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Robenacoxib
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Robenacoxib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 NDC API, 1 VMF, 2 Listed Suppliers, $ API Reference Price

2 API Suppliers
2 NDC API
1 VMF
2 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 6 Canada

6 FDF Dossiers
6 Canada

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 2 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 2 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 1 Clariant, 2 DFE Pharma, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Kerry, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

1 SPI Pharma
1 DKSH
2 Faran Shimi Pharmaceutical
5 Boai NKY Pharmaceuticals Ltd
2 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
1 Alcedo Pharmachem
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
15 BASF
1 Clariant
2 DFE Pharma
6 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
4 Kerry
9 Microlex e.U
1 Nanjing Bold Chemical
2 Novo Excipients
3 Pharmatrans-Sanaq
2 Pluviaendo
2 Prachin Chemical
7 Roquette
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
8 Sigachi Industries
1 Ulanqab Kema New Material
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

27 Fillers, Diluents & Binders, 18 Direct Compression, 16 Disintegrants & Superdisintegrants, 15 Thickeners and Stabilizers, 15 Granulation, 10 Lubricants & Glidants, 9 Solubilizers, 6 Controlled & Modified Release, 6 Co-Processed Excipients, 5 Chewable & Orodispersible Aids, 4 Coating Systems & Additives, 4 Parenteral, 4 Film Formers & Plasticizers, 4 Emulsifying Agents, 3 Topical, 2 Taste Masking, 2 Rheology Modifiers, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

27 Fillers, Diluents & Binders
18 Direct Compression
16 Disintegrants & Superdisintegrants
15 Thickeners and Stabilizers
15 Granulation
10 Lubricants & Glidants
9 Solubilizers
6 Controlled & Modified Release
6 Co-Processed Excipients
5 Chewable & Orodispersible Aids
4 Coating Systems & Additives
4 Parenteral
4 Film Formers & Plasticizers
4 Emulsifying Agents
3 Topical
2 Taste Masking
2 Rheology Modifiers
1 API Stability Enhancers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 NEWS #PharmaBuzz

1 NEWS #PharmaBuzz

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

$ API Ref.Price (USD/KG) : 10,821 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Gowling WLG (Canada) LLP

filter Patent Reset all filters

6 All

01 62298033

filter Product Reset all filters

6 All

01 6Robenacoxib

filter Dosage Reset all filters

6 All

01 1Solution for Injection

02 5Tablet

filter Exp Date Reset all filters

6 All

01 62018-08-26

Product Main Page

01

Gowling WLG (Canada) LLP

Robenacoxib

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Robenacoxib

Brand Name : ONSIOR

Patent Number : 2298033

Filing Date : 1998-08-26

Strength per Unit : 20 mg / mL

Dosage Form : Solution for Injection

Human Or VET : Veterinary

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Robenacoxib

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Robenacoxib

Brand Name : ONSIOR

Patent Number : 2298033

Filing Date : 1998-08-26

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling WLG (Canada) LLP

Robenacoxib

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Robenacoxib

Brand Name : ONSIOR

Patent Number : 2298033

Filing Date : 1998-08-26

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling WLG (Canada) LLP

Robenacoxib

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Robenacoxib

Brand Name : ONSIOR

Patent Number : 2298033

Filing Date : 1998-08-26

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Gowling WLG (Canada) LLP

Robenacoxib

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Robenacoxib

Brand Name : ONSIOR

Patent Number : 2298033

Filing Date : 1998-08-26

Strength per Unit : 40 mg

Dosage Form : Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Gowling WLG (Canada) LLP

Robenacoxib

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Robenacoxib

Brand Name : ONSIOR

Patent Number : 2298033

Filing Date : 1998-08-26

Strength per Unit : 6 mg

Dosage Form : Tablet

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2018-08-26

Date Granted : 2007-10-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!